Peptide sequences with strong stimulatory activity for lymphoid cells: implications for vaccine development.
Seven peptides derived from the bacterial major outer-membrane protein TraT were synthesized and then tested in lymphoproliferative assays using lymphoid cells from a variety of animals that had been immunized with the native TraT molecule in saline. A hierarchical pattern of responsiveness to the peptides was observed in the four animal species studied and in particular three of the peptides (T2, T4 and T6) showed very strong responses in all species. The 'universality' of the TraT-derived peptides was confirmed by studying the responsiveness of lymphoid cells obtained from the peripheral blood of twenty clinically normal human donors. Thus, following a secondary in vitro immunization with TraT-pulsed human peripheral blood mononuclear cells, responsiveness to TraT and to the TraT-derived peptides was observed in the cultures derived from all twenty donors. Taken together, our findings imply that the putative T-cell epitope peptides (T2, T4 and T6) could be employed as carriers in subunit vaccines and thereby help to overcome the unresponsiveness observed in animals and humans as a result of MHC restriction.
Russell-Jones
G J
GJ
Biotech Australia Pty Ltd., Roseville, Sydney.
Sullivan
J S
JS
Geczy
A F
AF
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000595:Amino Acid Sequence; D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology / Q000494:pharmacology; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology / Q000494:pharmacology*; D002417:Cattle; D004285:Dogs; D004337:Drug Carriers; D000939:Epitopes / Q000276:immunology*; D029968:Escherichia coli Proteins; D006801:Humans; D007114:Immunization; D008213:Lymphocyte Activation / Q000187:drug effects*; D008264:Macrophages / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000276:immunology / Q000494:pharmacology*; D012453:Saimiri; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology / Q000494:pharmacology*
D000276:Adjuvants, Immunologic; D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D004337:Drug Carriers; D000939:Epitopes; D029968:Escherichia coli Proteins; D010446:Peptide Fragments; C036297:TraT protein, E coli; D014614:Vaccines, Synthetic